1 Hu, FB & Willett, WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288, 2569–2578.
2 Sprecher, DL (1998) Triglycerides as a risk factor for coronary artery disease. Am J Cardiol 82, 49U–56U, .
3 Werner, RM & Pearson, TA (1998) LDL-cholesterol: a risk factor for coronary artery disease – from epidemiology to clinical trials. Can J Cardiol 14, Suppl. B, 3B–10B.
4 Cullen, P (2000) Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86, 943–949.
5 Regnstrom, J, Nilsson, J, Tornvall, P, Landou, C & Hamsten, A (1992) Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339, 1183–1186.
6 Reaven, PD (1994) Mechanisms of atherosclerosis: role of LDL oxidation. Adv Exp Med Biol 366, 113–128.
7 Wilt, TJ, Bloomfield, HE, MacDonald, R, Nelson, D, Rutks, I, Ho, M, Larsen, G, McCall, A, Pineros, S & Sales, A (2004) Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 164, 1427–1436.
8 Tucker, KL (2004) Dietary intake and coronary heart disease: a variety of nutrients and phytochemicals are important. Curr Treat Options Cardiovasc Med 6, 291–302.
9 Vasu, VT, Hiren, M, Thaikoottathil, JV & Gupta, S (2005) Hypolipideamic and antioxidant effect of Enicostemma littorale Blume aqueous extract in cholesterol fed rats. J Ethnopharmacol 101, 277–282.
10 Chu, YF & Liu, RH (2005) Cranberries inhibit LDL oxidation and induce LDL receptor expression in hepatocytes. Life Sci 77, 1892–1901.
11 Foresti, R, Hoque, M, Monti, D, Green, CJ & Motterlini, R (2005) Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J Pharmacol Exp Ther 312, 686–693.
12 Alcaraz, MJ, Fernandez, P & Guillen, MI (2003) Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 9, 2541–2551.
13 Fang, J, Akaike, T & Maeda, H (2004) Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis 9, 27–35.
14 Balla, J, Vercellotti, GM, Jeney, V, Yachie, A, Varga, Z, Eaton, JW & Balla, G (2005) Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 49, 1030–1043.
15 Chiang, LC, Chiang, W, Chang, MY & Lin, CC (2003) In vitro cytotoxic, antiviral and immunomodulatory effects of Plantago major and Plantago asiatica. Am J Chin Med 31, 225–234.
16 Berrougui, H, Cloutier, M, Isabelle, M & Khalil, A (2006) Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein. (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Atherosclerosis 184, 389–396.
17 Clegg, RJ, Middleton, B, Bell, GD & White, DA (1982) The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 257, 2294–2299.
18 von Bergmann, K, Beck, A, Engel, C & Leiss, O (1987) Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones. Klin Wochenschr 65, 458–462.
19 Lee, S, Moye, L, Campos, H, Williams, G & Sacks, F (2003) Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CЩ in patients with coronary heart disease. Atherosclerosis 167, 293–302.
20 Andreou, E & Prokipcak, R (1998) Analysis of human CYP7A1 mRNA decay in HepG2 cells by reverse transcription-polymerase chain reaction. Arch Biochem Biophys 357, 137–146.
21 Hasumi, M, Suzuki, K, Matsui, H, Koike, H, Ito, K & Yamanaka, H (2003) Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 200, 187–195.
22 Hanaka, S, Abe, T, Itakura, H & Matsumoto, A (2000) Gene expression related to cholesterol metabolism in mouse brain during development. Brain Dev 22, 321–326.
23 Han, SH, Chung, MJ, Lee, SJ & Rhee, C (2006) Digestion-resistant fraction from soybean [Glycine max (L.) Merrill] induces hepatic LDL receptor and CYP7A1 expression in apolipoprotein E-deficient mice. J Nutr Biochem 17, 682–688.
24 Wood, I, Hunter, H & Trayhurn, P (2003) Expression of class III facilitative glucose transporter genes (GLUT-10 and GLUT-12) in mouse and human adipose tissues. Biochem Biophys Res Commun 308, 43–49.
25 Witztum, JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344, 793–795.
26 Naderi, G, Asgary, S, Ani, M, Sarraf-Zadegan, N & Safari, M (2004) Effect of some volatile oils on the affinity of intact and oxidized low-density lipoproteins for adrenal cell surface receptors. Mol Cell Biochem 267, 59–66.
27 Brown, MS & Goldstein, JL (1985) Scavenger cell receptor shared. Nature 316, 680–681.
28 Cooper, AD (1997) Bile salt biosynthesis: an alternate synthetic pathway joins the mainstream. Gastroenterology 113, 2005–2008.
29 Smith, J, Osborne, T, Brown, M, Goldstein, J & Gil, G (1988) Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Biol Chem 263, 18480–18487.
30 Smith, J, Osborne, T, Goldstein, J & Brown, M (1990) Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J Biol Chem 265, 2306–2310.
31 Clarke, CF, Fogelman, AM & Edwards, PA (1985) Transcriptional regulation of the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene in rat liver. J Biol Chem 260, 14363–14367.
32 Molowa, DT & Cimis, GM (1989) Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells. Biochem J 260, 731–736.